Each year, more than 3 million people in the U.S. get an antimicrobial-resistant infection or Clostridioides difficile infection (often associated with taking antibiotics). In fiscal year 2023, CDC invested more than $155 million of annual funding to support health departments and partners in the United States and abroad to combat and prevent antimicrobial-resistant infections. CDC also invested more than $265 million from temporary supplemental funding to fight a range of infections that threaten the nation’s health, including those caused by antimicrobial-resistant organisms, COVID-19, and other known and emerging infectious diseases.
CDC leads the U.S. public health response to combat AR, a threat that continues to emerge and spread across the world. CDC’s AR Solutions Initiative invests in national infrastructure to detect, respond to, contain, and prevent resistant infections across healthcare settings, communities, the food supply, and the environment (water, soil). With sustained resources, CDC will continue to support its domestic and global AR programs to respond to whatever threat comes next.
Highlights of this year’s AR Investment Map release include:
- An interactive map showcasing CDC’s AR funding to support activities in every U.S. state health department and across nearly 100 public health partners.
- An updated fact sheet featuring CDC’s global investments with partners in more than 60 countries to improve detection, prevention, and response to AR threats internationally.
- An updated fact sheet showing how CDC’s one-time supplemental funding supports investments in IPC; training and capacity building, such as Project Firstline; surveillance; and public health personnel.
- New features to improve accessibility for all users. These updates include the ability to enable accessibility features through a toggle at the top of the screen; view all fact sheet content in HTML and PDF format; and use interactive page elements like unique links and buttons to improve website navigation.
